ADMA Biologics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 11/12/2025 | 35.63 M | $522.36 M | -2.31% | 14.75% |
| VANGUARD GROUP INC | 11/07/2025 | 20.97 M | $307.49 M | -1.82% | 8.69% |
| STATE STREET CORP | 11/14/2025 | 13.56 M | $198.81 M | 12.28% | 5.62% |
| INVESCO LTD. | 11/13/2025 | 12.51 M | $183.33 M | -2.44% | 5.18% |
| SACHEM HEAD CAPITAL MANAGEMENT LP | 11/14/2025 | 8.96 M | $131.35 M | 100.00% | 3.71% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 5.81 M | $85.24 M | -1.68% | 2.41% |
| NUVEEN, LLC | 11/12/2025 | 5.72 M | $83.92 M | 2.90% | 2.37% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 11/12/2025 | 5.11 M | $74.87 M | 100.00% | 2.11% |
| DIMENSIONAL FUND ADVISORS LP | 11/12/2025 | 4.80 M | $70.34 M | 0.74% | 1.99% |
| AMERICAN CENTURY COMPANIES INC | 11/12/2025 | 4.70 M | $68.84 M | 1.84% | 1.94% |
| THRIVENT FINANCIAL FOR LUTHERANS | 11/04/2025 | 4.14 M | $60.72 M | 24.93% | 1.72% |
| CAPITAL RESEARCH GLOBAL INVESTORS | 11/13/2025 | 3.25 M | $47.70 M | 100.00% | 1.35% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 2.91 M | $42.67 M | 59.90% | 1.21% |
| FRANKLIN RESOURCES INC | 11/13/2025 | 2.84 M | $104.30 M | 4.38% | 1.18% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 2.77 M | $40.61 M | -11.94% | 1.15% |
| OBERWEIS ASSET MANAGEMENT INC/ | 11/17/2025 | 2.71 M | $39.76 M | -13.52% | 1.12% |
| CALIGAN PARTNERS LP | 11/14/2025 | 2.64 M | $38.65 M | 100.00% | 1.09% |
| B GROUP, INC. | 11/14/2025 | 2.41 M | $35.37 M | 4.10% | 1.00% |
| NORTHERN TRUST CORP | 11/14/2025 | 2.36 M | $34.61 M | -3.38% | 0.98% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 2.36 M | $34.61 M | -5.65% | 0.98% |
| RANGER INVESTMENT MANAGEMENT, L.P. | 11/05/2025 | 2.34 M | $34.32 M | -2.08% | 0.97% |
| AWM INVESTMENT COMPANY, INC. | 11/13/2025 | 2.20 M | $32.25 M | 0.00% | 0.91% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2025 | 2.16 M | $31.60 M | 0.77% | 0.89% |
| PERPETUAL LTD | 10/10/2025 | 2.12 M | $31.07 M | -26.78% | 0.88% |
| CITADEL ADVISORS LLC | 11/14/2025 | 2.12 M | $31.07 M | 100.00% | 0.88% |
| UBS GROUP AG | 11/13/2025 | 1.99 M | $29.14 M | -17.92% | 0.82% |
| DEUTSCHE BANK AG\ | 11/13/2025 | 1.72 M | $25.19 M | -8.19% | 0.71% |
| ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC | 10/20/2025 | 1.55 M | $23.30 M | -53.37% | 0.64% |
| MORGAN STANLEY | 11/14/2025 | 1.46 M | $21.38 M | -25.66% | 0.60% |
| VOYA INVESTMENT MANAGEMENT LLC | 10/09/2025 | 1.45 M | $21.32 M | 3.95% | 0.60% |
| BANK OF NEW YORK MELLON CORP | 11/03/2025 | 1.42 M | $20.87 M | -5.06% | 0.59% |
| ROYAL BANK OF CANADA | 11/14/2025 | 1.41 M | $20.61 M | 99.86% | 0.58% |
| MACQUARIE GROUP LTD | 11/13/2025 | 1.40 M | $20.45 M | -11.40% | 0.58% |
| PRINCIPAL FINANCIAL GROUP INC | 11/04/2025 | 1.32 M | $19.40 M | -14.45% | 0.55% |
| POINT72 ASSET MANAGEMENT, L.P. | 11/14/2025 | 1.32 M | $19.38 M | 100.00% | 0.55% |
| METLIFE INVESTMENT MANAGEMENT, LLC | 11/13/2025 | 1.31 M | $19.21 M | 100.00% | 0.54% |
| OPHIR ASSET MANAGEMENT PTY LTD | 11/14/2025 | 1.26 M | $18.40 M | 2.81% | 0.52% |
| RAYMOND JAMES FINANCIAL INC | 11/14/2025 | 1.25 M | $18.35 M | -17.76% | 0.52% |
| RUSSELL INVESTMENTS GROUP, LTD. | 11/13/2025 | 1.24 M | $18.14 M | -31.99% | 0.51% |
| PFM HEALTH SCIENCES, LP | 11/14/2025 | 1.18 M | $17.31 M | 100.00% | 0.49% |
| PERCEPTIVE ADVISORS LLC | 11/14/2025 | 1.15 M | $16.91 M | -11.51% | 0.48% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 1.12 M | $16.49 M | -6.97% | 0.47% |
| ABRDN PLC | 11/07/2025 | 1.12 M | $16.37 M | 109.92% | 0.46% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 1.07 M | $15.72 M | 15.24% | 0.44% |
| FIRST LIGHT ASSET MANAGEMENT, LLC | 11/14/2025 | 1.07 M | $15.67 M | 12.30% | 0.44% |
| TANG CAPITAL MANAGEMENT LLC | 11/14/2025 | 1.05 M | $15.39 M | 0.00% | 0.43% |
| BALYASNY ASSET MANAGEMENT L.P. | 11/14/2025 | 1.02 M | $14.93 M | 4.82% | 0.42% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 945.90 K | $13.87 M | 18.43% | 0.39% |
| ROYCE & ASSOCIATES LP | 11/12/2025 | 932.07 K | $13.66 M | 45.81% | 0.39% |
| PUBLIC SECTOR PENSION INVESTMENT BOARD | 11/06/2025 | 930.80 K | $13.65 M | 14.36% | 0.39% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
ADMA Biologics, Inc. institutional Ownership - FAQ's
During the previous two years, 472 institutional investors and hedge funds held shares of ADMA Biologics, Inc.. The most heavily invested institutionals were:
BlackRock, Inc.: 35.63 M
VANGUARD GROUP INC: 20.97 M
STATE STREET CORP: 13.56 M
Invesco Ltd.: 12.51 M
Sachem Head Capital Management LP: 8.96 M
GEODE CAPITAL MANAGEMENT, LLC: 5.81 M
90.77% of ADMA Biologics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 251.75 M shares in the last 24 months. This purchase volume represents approximately $3.69 B in transactions.